CD28 and neoplasm: The poor DFS observed in young LUAD patients associated with higher CD28 or PD-L1+CD28+ T-cell levels has prompted Authors to suggest that high basal CD28 levels may exhaust the ability to reverse tumor immune suppression, likely due to higher levels of chronic activation, resulting in immune escape and poor DFS.